© PHARMED CANADA

​7:45-8:30

Registration and Coffee Networking

​8:30 - 8:35

 Welcome Remark

 Perry Niro, President, Pharmed Canada 

 

9:00 - 9:30

Global life sciences sector outlook

2016 Deals, M&A and partnering forecast for 2017

 

​9:30-10:15

Partnering across the borders with Pharma Ventures

  ​

Moderated by Anie Perrault, Executive Director, BIOQuébec

  • Jennifer Hamilton, Senior Director, New Ventures (Canada), Johnson & Johnson Innovation

  • Steven Xanthoudakis, Director, Business Development & Licensing at Merck

  • Amyn Sayani, Ph.D., Director, R&D Alliances, GlaxoSmithKline Canada

Networking Break

Program 2016  ( Agende 2017 available soon) 

Networking Break

​14:30 - 15:30

How to commecialize Digital Health and Medical Technologies

Moderated by  Jean-Francois PariseauPartnerHealthcare Fund, BDC Venture Capital

  • Ajit Singh, Partner, Artiman Ventures , Palo Alto

  • Daniel Hétu, Managing Director, Lumira Capital, Montréal

  • Kelly Holman, co-founder, Genesys Capital, Toronto
     

Luncheon Conference - Megatrends: Health Re-Imagined
 
  • Gautam Jaggi, Director, EY USA

​10:15 - 10:35

​16:45- 17:00    NEW  

Biomed Propulsion, a new commercialization program of $ 100 million in life sciences

  • Vanessa Claveau, Chef d'équipe, Direction des sciences de la vie, Ministère de l’Économie, de la Science et de l’Innovation

  • Pierre Tessier, Directeur principal du financement spécialisé, Investissement Québec

​10:35 - 11:30

Cross-border VC Deals: Joining the dots

Moderated by Stephen Nagler, Executive Director, MedPro Investors,  New York

  • Alex Zisson, Managing Director, HIG Capital, New York

  • Caroline Stout, Investor, EcoR1 Capital,  San Francisco

  • Elizabeth Douville, General Partner, GeneChem

​15:30 15:45

​15:45 - 16:45

Healthcare: Opportunities & Challenges for Medtech

 

  •  Yvan Beaudoin,  Executive Director, CTS Santé Fund

  •  Steeve Asselin, Industrial Technology Advisor,  (MedTech), National Research Council

  •  Stéphane Pillette, Vice-President, Healthcare & Life Sciences,   Anges Quebec

  • Arndt Welsch-Lehmann, Managing Partner, FOS Capital Partners, LLC, New York

17:00

Closing Remarks  & Networking Cocktail

​13:30 - 14:00 : 

Startup Pitches

New this year, three companies will be invited to make a 5 minute pitch to our audience. 

  • Francois Michaud, CEO, Feldan Therapeutics

  • Frédéric Leduc, Ph. D. , CEO, Immune Biosolutions

  • Maxime Ranger, CEO, Mperia Therapeutics Inc

14:00 - 14h30

Life Sciences EY Report 2016

Beyond borders,  Reaching new heights

  •  Lara Iob, CPA, Partner, EY Canada

  •  Yann Lavallee, Partner, EY Canada

​11:30 - 12:15

CEO Panel : Show me the money, dealing with VC's !

Moderated by Didier Leconte, Senior Director, Investments - Life Sciences, FSFTQ

  • David Young, M.D, KisoJi Biotechnology, Montréal

  • Philippe Douville , Founder and Chief Executive Officer, Milestone Pharmaceuticals Inc.

  • Michael Midmer, CEO, Zucara Therapeutics, Toronto

  • Lloyd Segal, EIR, Versant Ventures

​8:35 - 9:00

Opening Conference

Normand Chouinard, First  Vice-President, Investments,  Fonds de solidarité FTQ